Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MDRNA, Inc. Receives Full FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis; Par Pharmaceutical Companies, Inc. Launches Product
Yahoo
Tuesday, June 9, 2009 - 8:45am
tags:
Par Pharmaceutical, osteoporosis, FDA, ANDAs
More women breaking biotech's glass ceiling
Fierce Biotech
Tuesday, June 9, 2009 - 8:43am
tags:
biotech
How Close Avastin Really Came To Adjuvant Colorectal Cancer Use
InVivo
Tuesday, June 9, 2009 - 8:41am
tags:
colorectal cancer, cancer, Avastin, Roche, Genentech
Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
Yahoo
Tuesday, June 9, 2009 - 7:43am
tags:
Isis Pharmaceuticals, obesity, antisense, ADA, diabetes
Roche to Start Final Tests on Potential Diabetes Drug
Bloomberg
Tuesday, June 9, 2009 - 7:42am
tags:
Roche, diabetes, drug trials, Aleglitazar
How Will a Single Payer Health Care System Affect Pharmaceutical Prices?
Seeking Alpha
Tuesday, June 9, 2009 - 7:40am
tags:
healthcare reform, drug prices
CSL Ends $3.1 Billion Talecris Buyout, Announces Shares Buyback
Bloomberg
Monday, June 8, 2009 - 9:57pm
tags:
CSL, Talecris, buyouts
Time to scoop up some shares of Lilly
Blogging Stocks
Monday, June 8, 2009 - 9:50pm
tags:
Eli Lilly
AEterna Zentaris cancer drug missed trial goal
Yahoo/AP
Monday, June 8, 2009 - 9:48pm
tags:
Aeterna Zentaris, cancer, drug trials, perifosine
Got Merck ?
Barron's
Monday, June 8, 2009 - 7:12pm
tags:
Merck
ADA trials boost Januvia, question costly meds
Fierce Pharma
Monday, June 8, 2009 - 2:53pm
tags:
ADA, diabetes, Merck, Januvia, Avandia, Actos, GSK, Takeda, Novo Nordisk, Amylin
Waxman pushes Obama administration for early action to lower biotech drug costs
Yahoo/AP
Monday, June 8, 2009 - 2:52pm
tags:
Obama, biotech
CytRx rises on analyst's 'Outperform' rating
Yahoo/AP
Monday, June 8, 2009 - 2:51pm
tags:
CytRx
[video]Giant Leap for Mannkind
CNBC
Monday, June 8, 2009 - 1:10pm
tags:
MannKind, inhaled insulin, diabetes
Arena rises after reporting new obesity drug data
Yahoo/AP
Monday, June 8, 2009 - 1:06pm
tags:
Arena Pharmaceuticals, obesity
PDL BioPharma rises on better-than-seen outlook
Yahoo/AP
Monday, June 8, 2009 - 11:16am
tags:
PDL Biopharma, Avastin, Synagis
FDA panel to weigh risk of antipsychotics in kids
Fierce Pharma
Monday, June 8, 2009 - 11:14am
tags:
FDA, antipsychotics
Keryx Biopharmaceuticals shares jump as kidney disease drug meets midstage study goal
Yahoo/AP
Monday, June 8, 2009 - 11:12am
tags:
Keryx, drug trials, kidney disease, Zerenex
[video]Diabetes Drug Battle Royale
CNBC
Monday, June 8, 2009 - 11:11am
tags:
diabetes, Carl Icahn, Amylin
Dyax's response for more information on DX-88 gets FDA acceptance, decision expected by Dec.
Yahoo/AP
Monday, June 8, 2009 - 10:03am
tags:
Dyax, FDA, DX-88, angioedema

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.